Ulrich RuemenappSenior Biotech Program Lead at Bayer AGSpeaker
Profile
Dr. Rümenapp is based in Berlin, Germany and working within the Bayer Pharma Product Supply organization, Strategy & Excellence, where he is leading strategic initiatives incl. partnering projects with externals for biotech products, e.g., proteins, antibodies or antibody-drug-conjugates.
Prior to that, Dr. Rümenapp worked in Bayer’s Biologics Product Supply and development organization and was Head of Projects in Biotech Contract Manufacturing, where he was responsible for contract manufacturing partnerships to ensure timely development, launch and market supply.
Before it was acquired by Bayer, Dr. Rümenapp hold a similar position at Schering AG, and he started his career in the Production & Logistics department of Schering, being responsible for production aspects of licensing deals, due diligences, and product acquisitions of small molecule products and biologics.
Dr. Rümenapp studied chemistry and holds a Ph.D. in biosciences. He worked several years in academic biosciences research and as an assistant teacher in general pharmacology.
Agenda Sessions
Panel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices
, 14:00View SessionPanel Discussion: Cell and Gene Therapy CDMO Selection and External Manufacturing Best Practices
, 14:00View Session
